Strength-duration properties of peripheral nerve in acquired neuromyotonia

Muscle and Nerve

Volumn 22, Issue 7, 1999, Pages 823-830

  Maddison, Paul ^a   Newsom Davis, John ^a   Mills, Kerry R ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Acquired neuromyotonia; Strength duration time constant; Voltage gated potassium channels

Indexed keywords

ADULT; AGED; ARTICLE; CHANNEL GATING; CLINICAL ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; HUMAN; MEDIAN NERVE; MOTOR NERVE; MYOKYMIA; NERVE CONDUCTION; NERVE EXCITABILITY; NERVE FIBER MEMBRANE POTENTIAL; NERVE STIMULATION; PERIPHERAL NERVE; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; HUMANS; ION CHANNEL GATING; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; MYOTONIA; NEURAL CONDUCTION; NEUROMUSCULAR DISEASES; PERIPHERAL NERVES; POTASSIUM CHANNELS; TIME FACTORS;

EID: 0032777485     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199907)22:7<823::AID-MUS3>3.0.CO;2-1     Document Type: Article

References (45)

1. Baker M, Bostock H, Grafe P, Martius P. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J Physiol 1987;383:45-67.
2. Benoit E, Dubois JM. Toxin I from the snake Dendroaspis polylepis polylepis: a highly specific blocker of one type of potassium channel in myelinated nerve fiber. Brain Res 1986; 377:374-377.
3. Bono A, Beghi E, Bogliun G, Cavaletti G, Curtó N, Marzorati L, Frattola L, and the Collaborative Group for the Study of Epilepsy. Antiepileptic drugs and peripheral nerve function: a multicenter screening investigation of 141 patients with chronic treatment. Epilepsia 1993;34:323-331.
4. Bostock H. The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J. Physiol 1983;341:59-74.
5. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137-158.
6. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 1997;498:277-294.
7. Bostock H, Sears TA, Sherratt RM. The spatial distribution of excitability and membrane current in normal and demyelinated mammalian nerve fibres. J Physiol 1983;341:41-58.
8. Bostock H, Sharief MK, Reid G, Murray NM. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995; 118:217-225.
9. + channel in Xenopus nerve fibres selectively blocked by bee and snake toxins: binding and voltage-clamp experiments. J Physiol 1990;420:365-385.
10. Brismar T. Electrical properties of isolated demyelinated rat nerve fibres. Acta Physiol Scand 1981;113:161-166.
11. Brismar T. Changes in electrical threshold in human peripheral nerve. J Neurol Sci 1985;68:215-223.
12. Chiu SY, Ritchie JM. Potassium channels in nodal and internodal axonal membrane in mammalian myelinated fibres. Nature 1980;284:170-171.
13. Eng DL, Gordon TR, Kocsis JD, Waxman SG. Development of 4-AP and TEA sensitivities in mammalian myelinated nerve fibers. J Neurophysiol 1988;60:2168-2179.
14. García-Merino A, Cabello A, Mora JS, Liaño H: Continuous muscle fiber activity, peripheral neuropathy, and thymoma. Ann Neurol 1991;29:215-218.
15. Hahn AF, Parkes AW, Bolton CF, Stewart SA. Neuromyotonia in hereditary motor neuropathy. J Neurol Neurosurg Psychiatry 1991;54:230-235.
16. + channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-246.
17. Hosokawa S, Shinoda H, Sakai T, Kato M, Kuroiwa Y. Electrophysiological study on limb myokymia in three women. J Neurol Neurosurg Psychiatry 1987;50:877-881.
18. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319-325.
19. Kiernan MC, Mogyoros I, Burke D. Differences in the recovery of excitability in sensory and motor axons of human median nerve. Brain 1996;119:1099-1105.
20. Kimura J. Electrodiagnosis on diseases of nerve and muscle: principles and practice. Philadelphia: FA Davis; 1983. p 105-141.
21. Kocsis JD, Eng DL, Gordon TR, Waxman SG. Functional differences between 4-aminopyridine and tetraethylammonium-sensitive potassium channels in myelinated axons. Neurosci Lett 1987;75:193-198.
22. Kocsis JD, Bowe CM, Waxman SG. Different effects of 4-aminopyridine on sensory and motor fibres: pathogenesis of paresthesias. Neurology 1986; 36:117-120.
23. Kocsis JD, Waxman SG, Hildebrand C, Ruiz JA. Regenerating mammalian nerve fibres: changes in action potential waveform and firing characteristics following blockage of potassium conductance. Proc R Soc Lond B Biol Sci 1982;217: 277-287.
24. Kukowski B, Feldmann M. Neuromyotonia: report of a case. Clin Invest 1992;70:517-519.
25. Lance JW, Burke D, Pollard J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann Neurol 1979;5: 523-532.
26. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1995;36(suppl 2):S2-S12.
27. McLeod JG. Electrophysiological studies in the Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):20-27.
28. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996;119:439-447.
29. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of sensory and motor axons in carpal tunnel syndrome. Muscle Nerve 1997;20:508-510.
30. Mogyoros I, Kiernan MC, Burke D, Bostock H. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998;121:851-859.
31. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): report of five cases and literature review. Brain 1993;116:453-469.
32. Ono S, Munakata S, Nagao K, Shimizu N, Shimizu N. The syndrome of continuous muscle fibre activity: light and electron microscopic studies in muscle and nerve biopsies. J Neurol 1989;236:377-381.
33. Partanen VSJ, Soininen H, Saksa M, Riekkinen P. Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer. Acta Neurol Scand 1980;61:216-226.
34. Panizza M, Nilsson J, Roth BJ, Rothwell J, Hallett M. The time constants of motor and sensory peripheral nerve fibres measured with the method of latent addition. Electroencephalogr Clin Neurophysiol 1994;93: 147-154.
35. Rettig J, Heinemann SH, Wunder F, Lorra C, Parcej DN, Dolly JO, Pongs O. Inactivation properties of voltage-gated K+ channels altered by presence of β-subunit. Nature 1994;369: 289-294.
36. Ritchie JM. Sodium and potassium channels in regenerating and developing mammalian myelinated nerves. Proc R Soc Lond B Biol Sci 1982;215:273-287.
37. Richie G, Trouillas P, Bady B. Improvement of Isaacs' syndrome after treatment with azathioprine. J Neurol Neurosurg Psychiatry 1995;59:448.
38. + channels. Neuroscience 1988;25:729-749.
39. + channels of peripheral nerves. Ann Neurol 1995;38:714-722.
40. Toyka K, Zielasek J, Ricker K, Adlkofer K, Suter U. Hereditary neuromyotonia: a mouse model associated with deficiency or increased gene dosage of the PMP22 gene. J Neurol Neurosurg Psychiatry 1997;62:812-813.
41. Vasilescu C, Alexianu M, Dan A. Muscle hypertrophy and a syndrome of continuous motor unit activity in prednisolone-responsive Guillain-Barré polyneuropathy. J Neurol 1984; 231:276-279.
42. Wallis WE, Van-Poznak A, Plum F. Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin. Arch Neurol 1970;22:430-439.
43. Walsh JC. Neuromyotonia: an unusual presentation of intrathoracic malignancy. J Neurol Neurosurg Psychiatry 1976;39: 1086-1091.
44. Weiss G. Sur la possibilite de rendre comparables entre eux les appareils servant a l'excitation electrique. Arch Ital Biol 1901;35:413-446.
45. Welch LK, Appenzeller O, Bicknell JM. Peripheral neuropathy with myokymia, sustained muscular contraction, and continuous motor activity. Neurology 1972;22:161-169.